Home › Mantle Cell Lymphoma › California › Baldwin Park
Mantle Cell Lymphoma clinical trials in Baldwin Park, CA
16 studies for Mantle Cell Lymphoma are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
RecruitingPhase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- City of Hope, Duarte · 4 mi away
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
RecruitingPhase 1/2
- City of Hope Medical center, Duarte · 4 mi away
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- City of Hope, Duarte · 4 mi away
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
RecruitingPhase 2
- City of Hope Medical Center, Duarte · 4 mi away
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
RecruitingPhase 2
- City of Hope Medical Center, Duarte · 4 mi away
Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
RecruitingPhase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Duarte · 4 mi away
Mantle Cell Lymphoma trials in other cities
- Houston, TX15 studies
- Seattle, WA13 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Milwaukee, WI12 studies
- New York City, NY12 studies
- Boston, MA11 studies
- Chicago, IL10 studies
- Nashville, TN10 studies
- Portland, OR9 studies
- Rochester, MN9 studies
- Denver, CO8 studies
Other studies in Baldwin Park
- Breast Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Colorectal Cancer38 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)32 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Myelodysplastic Syndromes26 studies
- Ovarian Cancer25 studies
- Lung Cancer24 studies
- Multiple Myeloma23 studies
- Stomach Cancer21 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.